nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL21—rheumatoid arthritis	0.0282	0.0427	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—BDKRB2—rheumatoid arthritis	0.0232	0.0352	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CCL21—rheumatoid arthritis	0.0182	0.0275	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DRB5—rheumatoid arthritis	0.0152	0.0231	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQA2—rheumatoid arthritis	0.0152	0.0231	CbGpPWpGaD
Azilsartan medoxomil—Blood creatine phosphokinase increased—Leflunomide—rheumatoid arthritis	0.0122	0.0357	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—ETS1—rheumatoid arthritis	0.0119	0.0181	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL13—rheumatoid arthritis	0.0112	0.017	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—NOS3—rheumatoid arthritis	0.0108	0.0164	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CX3CR1—rheumatoid arthritis	0.0105	0.016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—FOXP3—rheumatoid arthritis	0.00962	0.0146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL6—rheumatoid arthritis	0.00943	0.0143	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—C5—rheumatoid arthritis	0.00929	0.0141	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR6—rheumatoid arthritis	0.00921	0.014	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL21—rheumatoid arthritis	0.00899	0.0136	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—GZMB—rheumatoid arthritis	0.00823	0.0125	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Penicillamine—rheumatoid arthritis	0.00775	0.0228	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PTK2—rheumatoid arthritis	0.0076	0.0115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL17A—rheumatoid arthritis	0.00757	0.0115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CD28—rheumatoid arthritis	0.00736	0.0112	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Auranofin—rheumatoid arthritis	0.00736	0.0216	CcSEcCtD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—TGFB1—rheumatoid arthritis	0.00717	0.0109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—BDKRB2—rheumatoid arthritis	0.00716	0.0108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DPB1—rheumatoid arthritis	0.00698	0.0106	CbGpPWpGaD
Azilsartan medoxomil—Hyperuricaemia—Cyclosporine—rheumatoid arthritis	0.00696	0.0205	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL12—rheumatoid arthritis	0.00679	0.0103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CD40—rheumatoid arthritis	0.00672	0.0102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CTLA4—rheumatoid arthritis	0.00662	0.01	CbGpPWpGaD
Azilsartan medoxomil—Blood uric acid increased—Cyclosporine—rheumatoid arthritis	0.00657	0.0193	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL6—rheumatoid arthritis	0.00632	0.00959	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Penicillamine—rheumatoid arthritis	0.00629	0.0185	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—STAT1—rheumatoid arthritis	0.00609	0.00923	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL21—rheumatoid arthritis	0.00603	0.00914	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Penicillamine—rheumatoid arthritis	0.00589	0.0173	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQA1—rheumatoid arthritis	0.00583	0.00883	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Ergocalciferol—rheumatoid arthritis	0.00578	0.017	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—rheumatoid arthritis	0.00576	0.00873	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL13—rheumatoid arthritis	0.00556	0.00842	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DQB1—rheumatoid arthritis	0.00545	0.00826	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1A—rheumatoid arthritis	0.00518	0.00785	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL10—rheumatoid arthritis	0.00515	0.0078	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CD40LG—rheumatoid arthritis	0.00515	0.0078	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL4—rheumatoid arthritis	0.00501	0.00759	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CX3CR1—rheumatoid arthritis	0.00495	0.00751	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide GPCRs—CCR5—rheumatoid arthritis	0.00491	0.00744	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-B—rheumatoid arthritis	0.0049	0.00742	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—rheumatoid arthritis	0.00488	0.0074	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL6—rheumatoid arthritis	0.00482	0.0073	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Ergocalciferol—rheumatoid arthritis	0.00479	0.0141	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—FASLG—rheumatoid arthritis	0.00479	0.00725	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Auranofin—rheumatoid arthritis	0.00465	0.0137	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—FAS—rheumatoid arthritis	0.00462	0.007	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—C5—rheumatoid arthritis	0.0046	0.00698	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL21—rheumatoid arthritis	0.00459	0.00696	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL2RA—rheumatoid arthritis	0.00459	0.00696	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—rheumatoid arthritis	0.00458	0.00694	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—C3—rheumatoid arthritis	0.00455	0.0069	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-A—rheumatoid arthritis	0.00454	0.00688	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Auranofin—rheumatoid arthritis	0.0045	0.0132	CcSEcCtD
Azilsartan medoxomil—Blood creatinine increased—Cyclosporine—rheumatoid arthritis	0.00439	0.0129	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR6—rheumatoid arthritis	0.00433	0.00656	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Penicillamine—rheumatoid arthritis	0.00415	0.0122	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	0.00415	0.00628	CbGpPWpGaD
Azilsartan medoxomil—Rash—Auranofin—rheumatoid arthritis	0.00414	0.0122	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Auranofin—rheumatoid arthritis	0.00414	0.0122	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Leflunomide—rheumatoid arthritis	0.00414	0.0122	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Leflunomide—rheumatoid arthritis	0.00413	0.0121	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL3—rheumatoid arthritis	0.00396	0.006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL2—rheumatoid arthritis	0.00396	0.006	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—SAA1—rheumatoid arthritis	0.00392	0.00594	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Auranofin—rheumatoid arthritis	0.0039	0.0115	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CX3CR1—rheumatoid arthritis	0.00388	0.00588	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—SAA1—rheumatoid arthritis	0.00387	0.00587	CbGpPWpGaD
Azilsartan medoxomil—Hyperuricaemia—Methotrexate—rheumatoid arthritis	0.00384	0.0113	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CD80—rheumatoid arthritis	0.00383	0.00581	CbGpPWpGaD
Azilsartan medoxomil—Rash—Penicillamine—rheumatoid arthritis	0.00383	0.0112	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Penicillamine—rheumatoid arthritis	0.00382	0.0112	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL13—rheumatoid arthritis	0.00373	0.00565	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—rheumatoid arthritis	0.00363	0.00551	CbGpPWpGaD
Azilsartan medoxomil—Blood uric acid increased—Methotrexate—rheumatoid arthritis	0.00363	0.0107	CcSEcCtD
Azilsartan medoxomil—Nausea—Penicillamine—rheumatoid arthritis	0.0036	0.0106	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—rheumatoid arthritis	0.00357	0.00541	CbGpPWpGaD
Azilsartan medoxomil—Muscle spasms—Leflunomide—rheumatoid arthritis	0.00351	0.0103	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—SAA1—rheumatoid arthritis	0.00351	0.00532	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—BDKRB2—rheumatoid arthritis	0.00341	0.00517	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—rheumatoid arthritis	0.00339	0.00514	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—ADRBK1—rheumatoid arthritis	0.00337	0.00511	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL12—rheumatoid arthritis	0.00337	0.0051	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—BDKRB2—rheumatoid arthritis	0.00337	0.0051	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Leflunomide—rheumatoid arthritis	0.00334	0.00982	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—rheumatoid arthritis	0.00332	0.00504	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.00327	0.00962	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Cyclosporine—rheumatoid arthritis	0.00318	0.00936	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—RASGRP1—rheumatoid arthritis	0.00318	0.00482	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PRKCQ—rheumatoid arthritis	0.00311	0.00472	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.00309	0.00909	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—C5—rheumatoid arthritis	0.00309	0.00468	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Azathioprine—rheumatoid arthritis	0.00307	0.00902	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—rheumatoid arthritis	0.00305	0.00462	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IFNG—rheumatoid arthritis	0.00303	0.00459	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—rheumatoid arthritis	0.00302	0.00457	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL10—rheumatoid arthritis	0.00298	0.00451	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Cyclosporine—rheumatoid arthritis	0.00294	0.00864	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.00293	0.0086	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—rheumatoid arthritis	0.0029	0.0044	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Leflunomide—rheumatoid arthritis	0.0029	0.00852	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—rheumatoid arthritis	0.00284	0.00431	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL13—rheumatoid arthritis	0.00284	0.0043	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Hydrocortisone—rheumatoid arthritis	0.00283	0.00832	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—rheumatoid arthritis	0.00283	0.00428	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL8—rheumatoid arthritis	0.00282	0.00427	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—rheumatoid arthritis	0.00278	0.00422	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.00273	0.00802	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL6—rheumatoid arthritis	0.00272	0.00413	CbGpPWpGaD
Azilsartan medoxomil—Muscle spasms—Cyclosporine—rheumatoid arthritis	0.00271	0.00797	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—rheumatoid arthritis	0.0027	0.00409	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL2—rheumatoid arthritis	0.00269	0.00408	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Methylprednisolone—rheumatoid arthritis	0.00266	0.00782	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—rheumatoid arthritis	0.00266	0.00403	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—rheumatoid arthritis	0.00266	0.00403	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—rheumatoid arthritis	0.00264	0.00399	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—SAA1—rheumatoid arthritis	0.0026	0.00394	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL21—rheumatoid arthritis	0.0026	0.00394	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Cyclosporine—rheumatoid arthritis	0.00258	0.00758	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.00258	0.00757	CcSEcCtD
Azilsartan medoxomil—Fatigue—Leflunomide—rheumatoid arthritis	0.00257	0.00756	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL5—rheumatoid arthritis	0.00256	0.00388	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CX3CR1—rheumatoid arthritis	0.00253	0.00383	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL6—rheumatoid arthritis	0.00247	0.00375	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—rheumatoid arthritis	0.00246	0.00373	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.00246	0.00722	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.00239	0.00701	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL21—rheumatoid arthritis	0.00236	0.00357	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C5—rheumatoid arthritis	0.00235	0.00356	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Prednisolone—rheumatoid arthritis	0.00235	0.0069	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR5—rheumatoid arthritis	0.00231	0.0035	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Hydrocortisone—rheumatoid arthritis	0.00229	0.00673	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—VEGFA—rheumatoid arthritis	0.00229	0.00347	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—rheumatoid arthritis	0.00226	0.00342	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—rheumatoid arthritis	0.00226	0.00342	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.00226	0.00664	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—C3—rheumatoid arthritis	0.00226	0.00342	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00224	0.00657	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Dexamethasone—rheumatoid arthritis	0.00223	0.00656	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Betamethasone—rheumatoid arthritis	0.00223	0.00656	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR6—rheumatoid arthritis	0.00221	0.00335	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Azathioprine—rheumatoid arthritis	0.00216	0.00635	CcSEcCtD
Azilsartan medoxomil—Angioedema—Triamcinolone—rheumatoid arthritis	0.00216	0.00634	CcSEcCtD
Azilsartan medoxomil—Angioedema—Methylprednisolone—rheumatoid arthritis	0.00215	0.00633	CcSEcCtD
Azilsartan medoxomil—Asthenia—Leflunomide—rheumatoid arthritis	0.00214	0.00629	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.00212	0.00623	CcSEcCtD
Azilsartan medoxomil—Pruritus—Leflunomide—rheumatoid arthritis	0.00211	0.0062	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.00211	0.00619	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TGFB1—rheumatoid arthritis	0.0021	0.00318	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Azathioprine—rheumatoid arthritis	0.00209	0.00614	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDE2A—rheumatoid arthritis	0.00206	0.00313	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Leflunomide—rheumatoid arthritis	0.00204	0.006	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL2—rheumatoid arthritis	0.00202	0.00307	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL3—rheumatoid arthritis	0.00202	0.00307	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.00201	0.0059	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	0.002	0.00302	CbGpPWpGaD
Azilsartan medoxomil—Rash—Azathioprine—rheumatoid arthritis	0.00199	0.00586	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.00199	0.00585	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Azathioprine—rheumatoid arthritis	0.00199	0.00585	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.00199	0.00584	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.00199	0.00584	CcSEcCtD
Azilsartan medoxomil—Fatigue—Cyclosporine—rheumatoid arthritis	0.00199	0.00584	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—SAA1—rheumatoid arthritis	0.00198	0.003	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Leflunomide—rheumatoid arthritis	0.00197	0.0058	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—rheumatoid arthritis	0.00196	0.00297	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Betamethasone—rheumatoid arthritis	0.00196	0.00575	CcSEcCtD
Azilsartan medoxomil—Angioedema—Dexamethasone—rheumatoid arthritis	0.00196	0.00575	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Prednisone—rheumatoid arthritis	0.00194	0.00572	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.00189	0.00554	CcSEcCtD
Azilsartan medoxomil—Rash—Leflunomide—rheumatoid arthritis	0.00188	0.00553	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Leflunomide—rheumatoid arthritis	0.00188	0.00552	CcSEcCtD
Azilsartan medoxomil—Nausea—Azathioprine—rheumatoid arthritis	0.00188	0.00552	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDE2A—rheumatoid arthritis	0.00187	0.00284	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.00187	0.00549	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	0.00181	0.00274	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—POMC—rheumatoid arthritis	0.0018	0.00273	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—rheumatoid arthritis	0.00179	0.00271	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Leflunomide—rheumatoid arthritis	0.00177	0.00521	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.00177	0.00519	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL2—rheumatoid arthritis	0.00176	0.00267	CbGpPWpGaD
Azilsartan medoxomil—Fatigue—Hydrocortisone—rheumatoid arthritis	0.00176	0.00519	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL12—rheumatoid arthritis	0.00172	0.00261	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—BDKRB2—rheumatoid arthritis	0.00172	0.00261	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	0.00172	0.0026	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.00171	0.00504	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.00171	0.00504	CcSEcCtD
Azilsartan medoxomil—Angioedema—Prednisone—rheumatoid arthritis	0.0017	0.00501	CcSEcCtD
Azilsartan medoxomil—Fatigue—Triamcinolone—rheumatoid arthritis	0.00166	0.00488	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methylprednisolone—rheumatoid arthritis	0.00166	0.00487	CcSEcCtD
Azilsartan medoxomil—Asthenia—Cyclosporine—rheumatoid arthritis	0.00165	0.00486	CcSEcCtD
Azilsartan medoxomil—Pruritus—Cyclosporine—rheumatoid arthritis	0.00163	0.00479	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Methotrexate—rheumatoid arthritis	0.00162	0.00478	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL13—rheumatoid arthritis	0.0016	0.00243	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—rheumatoid arthritis	0.00159	0.00242	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.00158	0.00464	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.00158	0.00463	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	0.00155	0.00235	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Cyclosporine—rheumatoid arthritis	0.00152	0.00448	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL10—rheumatoid arthritis	0.00152	0.0023	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	0.00151	0.00229	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00151	0.00444	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00151	0.00444	CcSEcCtD
Azilsartan medoxomil—Fatigue—Betamethasone—rheumatoid arthritis	0.00151	0.00443	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dexamethasone—rheumatoid arthritis	0.00151	0.00443	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Prednisone—rheumatoid arthritis	0.00149	0.00439	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Prednisone—rheumatoid arthritis	0.00148	0.00435	CcSEcCtD
Azilsartan medoxomil—Asthenia—Hydrocortisone—rheumatoid arthritis	0.00147	0.00432	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL6—rheumatoid arthritis	0.00146	0.00221	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL13—rheumatoid arthritis	0.00146	0.00221	CbGpPWpGaD
Azilsartan medoxomil—Rash—Cyclosporine—rheumatoid arthritis	0.00145	0.00427	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—rheumatoid arthritis	0.00145	0.0022	CbGpPWpGaD
Azilsartan medoxomil—Dermatitis—Cyclosporine—rheumatoid arthritis	0.00145	0.00426	CcSEcCtD
Azilsartan medoxomil—Pruritus—Hydrocortisone—rheumatoid arthritis	0.00145	0.00426	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.0014	0.00412	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL8—rheumatoid arthritis	0.0014	0.00211	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL21—rheumatoid arthritis	0.00139	0.00211	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SYVN1—rheumatoid arthritis	0.00139	0.00211	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisolone—rheumatoid arthritis	0.00139	0.00407	CcSEcCtD
Azilsartan medoxomil—Asthenia—Triamcinolone—rheumatoid arthritis	0.00138	0.00406	CcSEcCtD
Azilsartan medoxomil—Asthenia—Methylprednisolone—rheumatoid arthritis	0.00138	0.00405	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2RB—rheumatoid arthritis	0.00138	0.00209	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Cyclosporine—rheumatoid arthritis	0.00137	0.00402	CcSEcCtD
Azilsartan medoxomil—Pruritus—Triamcinolone—rheumatoid arthritis	0.00136	0.00401	CcSEcCtD
Azilsartan medoxomil—Pruritus—Methylprednisolone—rheumatoid arthritis	0.00136	0.004	CcSEcCtD
Azilsartan medoxomil—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00135	0.00398	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TAGAP—rheumatoid arthritis	0.00134	0.00202	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C5—rheumatoid arthritis	0.00133	0.00201	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisolone—rheumatoid arthritis	0.00132	0.00388	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisolone—rheumatoid arthritis	0.00132	0.00388	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00132	0.00387	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.00132	0.00387	CcSEcCtD
Azilsartan medoxomil—Fatigue—Prednisone—rheumatoid arthritis	0.00131	0.00386	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL5—rheumatoid arthritis	0.00131	0.00198	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CX3CR1—rheumatoid arthritis	0.0013	0.00197	CbGpPWpGaD
Azilsartan medoxomil—Rash—Hydrocortisone—rheumatoid arthritis	0.00129	0.00379	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.00129	0.00379	CcSEcCtD
Azilsartan medoxomil—Dizziness—Triamcinolone—rheumatoid arthritis	0.00127	0.00375	CcSEcCtD
Azilsartan medoxomil—Dizziness—Methylprednisolone—rheumatoid arthritis	0.00127	0.00374	CcSEcCtD
Azilsartan medoxomil—Asthenia—Betamethasone—rheumatoid arthritis	0.00125	0.00369	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dexamethasone—rheumatoid arthritis	0.00125	0.00369	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2RB—rheumatoid arthritis	0.00125	0.00189	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR6—rheumatoid arthritis	0.00125	0.00189	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.00125	0.00367	CcSEcCtD
Azilsartan medoxomil—Nausea—Prednisolone—rheumatoid arthritis	0.00124	0.00366	CcSEcCtD
Azilsartan medoxomil—Pruritus—Dexamethasone—rheumatoid arthritis	0.00124	0.00364	CcSEcCtD
Azilsartan medoxomil—Pruritus—Betamethasone—rheumatoid arthritis	0.00124	0.00364	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Methotrexate—rheumatoid arthritis	0.00124	0.00363	CcSEcCtD
Azilsartan medoxomil—Nausea—Hydrocortisone—rheumatoid arthritis	0.00122	0.00357	CcSEcCtD
Azilsartan medoxomil—Rash—Triamcinolone—rheumatoid arthritis	0.00121	0.00357	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Triamcinolone—rheumatoid arthritis	0.00121	0.00357	CcSEcCtD
Azilsartan medoxomil—Rash—Methylprednisolone—rheumatoid arthritis	0.00121	0.00356	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00121	0.00356	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	0.00121	0.00183	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C5—rheumatoid arthritis	0.00121	0.00183	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.0012	0.00352	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Betamethasone—rheumatoid arthritis	0.0012	0.00352	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	0.00118	0.00179	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR5—rheumatoid arthritis	0.00118	0.00179	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Betamethasone—rheumatoid arthritis	0.00116	0.0034	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dexamethasone—rheumatoid arthritis	0.00116	0.0034	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C3—rheumatoid arthritis	0.00115	0.00175	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Triamcinolone—rheumatoid arthritis	0.00114	0.00336	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL2—rheumatoid arthritis	0.00114	0.00173	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Methylprednisolone—rheumatoid arthritis	0.00114	0.00336	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR6—rheumatoid arthritis	0.00113	0.00172	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—SAA1—rheumatoid arthritis	0.00112	0.00169	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE2A—rheumatoid arthritis	0.00111	0.00168	CbGpPWpGaD
Azilsartan medoxomil—Rash—Betamethasone—rheumatoid arthritis	0.0011	0.00324	CcSEcCtD
Azilsartan medoxomil—Rash—Dexamethasone—rheumatoid arthritis	0.0011	0.00324	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dexamethasone—rheumatoid arthritis	0.0011	0.00324	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Betamethasone—rheumatoid arthritis	0.0011	0.00324	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.0011	0.00323	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methotrexate—rheumatoid arthritis	0.0011	0.00322	CcSEcCtD
Azilsartan medoxomil—Asthenia—Prednisone—rheumatoid arthritis	0.00109	0.00321	CcSEcCtD
Azilsartan medoxomil—Pruritus—Prednisone—rheumatoid arthritis	0.00108	0.00317	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLB1—rheumatoid arthritis	0.00106	0.0016	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Prednisone—rheumatoid arthritis	0.00104	0.00306	CcSEcCtD
Azilsartan medoxomil—Nausea—Betamethasone—rheumatoid arthritis	0.00104	0.00305	CcSEcCtD
Azilsartan medoxomil—Nausea—Dexamethasone—rheumatoid arthritis	0.00104	0.00305	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL3—rheumatoid arthritis	0.00104	0.00157	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL2—rheumatoid arthritis	0.00104	0.00157	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SAA1—rheumatoid arthritis	0.00102	0.00154	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisone—rheumatoid arthritis	0.00101	0.00296	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RBPJ—rheumatoid arthritis	0.000974	0.00148	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL12—rheumatoid arthritis	0.000972	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	0.000972	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	0.000961	0.00146	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisone—rheumatoid arthritis	0.00096	0.00282	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisone—rheumatoid arthritis	0.000959	0.00282	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	0.000936	0.00142	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—POMC—rheumatoid arthritis	0.000921	0.0014	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Methotrexate—rheumatoid arthritis	0.000913	0.00268	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	0.000906	0.00137	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Prednisone—rheumatoid arthritis	0.000904	0.00266	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL2—rheumatoid arthritis	0.000901	0.00137	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Methotrexate—rheumatoid arthritis	0.0009	0.00265	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	0.000887	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL12—rheumatoid arthritis	0.000883	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB2—rheumatoid arthritis	0.000883	0.00134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRBK1—rheumatoid arthritis	0.000873	0.00132	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000871	0.00256	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL13—rheumatoid arthritis	0.000861	0.0013	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL10—rheumatoid arthritis	0.000859	0.0013	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Methotrexate—rheumatoid arthritis	0.000841	0.00247	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—RASGRP1—rheumatoid arthritis	0.000823	0.00125	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PRKCQ—rheumatoid arthritis	0.000805	0.00122	CbGpPWpGaD
Azilsartan medoxomil—Rash—Methotrexate—rheumatoid arthritis	0.000802	0.00236	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Methotrexate—rheumatoid arthritis	0.000802	0.00236	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL10—rheumatoid arthritis	0.00078	0.00118	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TLE3—rheumatoid arthritis	0.000775	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IRAK1—rheumatoid arthritis	0.000775	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CX3CR1—rheumatoid arthritis	0.000767	0.00116	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Methotrexate—rheumatoid arthritis	0.000756	0.00222	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL5—rheumatoid arthritis	0.000739	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2RB—rheumatoid arthritis	0.000738	0.00112	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CSF2—rheumatoid arthritis	0.000728	0.0011	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C5—rheumatoid arthritis	0.000713	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL8—rheumatoid arthritis	0.000713	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—MMP3—rheumatoid arthritis	0.000711	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—rheumatoid arthritis	0.00071	0.00108	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NFATC1—rheumatoid arthritis	0.000701	0.00106	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL5—rheumatoid arthritis	0.000671	0.00102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR6—rheumatoid arthritis	0.00067	0.00102	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR5—rheumatoid arthritis	0.000666	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CSF2—rheumatoid arthritis	0.000661	0.001	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2RA—rheumatoid arthritis	0.000656	0.000995	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NCF2—rheumatoid arthritis	0.000652	0.000988	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C3—rheumatoid arthritis	0.000651	0.000987	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SH2B3—rheumatoid arthritis	0.000636	0.000963	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TRAF6—rheumatoid arthritis	0.000636	0.000963	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—GZMB—rheumatoid arthritis	0.000632	0.000957	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL3—rheumatoid arthritis	0.000613	0.000929	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL2—rheumatoid arthritis	0.000613	0.000929	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR5—rheumatoid arthritis	0.000605	0.000917	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SAA1—rheumatoid arthritis	0.0006	0.000909	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2RA—rheumatoid arthritis	0.000596	0.000904	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C3—rheumatoid arthritis	0.000591	0.000896	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NCF1—rheumatoid arthritis	0.000587	0.00089	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CD28—rheumatoid arthritis	0.000565	0.000856	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—UBE2D1—rheumatoid arthritis	0.000532	0.000806	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL12—rheumatoid arthritis	0.000521	0.00079	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB2—rheumatoid arthritis	0.000521	0.00079	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—POMC—rheumatoid arthritis	0.000521	0.000789	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6ST—rheumatoid arthritis	0.000517	0.000783	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRBK1—rheumatoid arthritis	0.000516	0.000781	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	0.000486	0.000737	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SYK—rheumatoid arthritis	0.000485	0.000735	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	0.000476	0.000721	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—POMC—rheumatoid arthritis	0.000473	0.000716	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT1—rheumatoid arthritis	0.000467	0.000708	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL2—rheumatoid arthritis	0.000463	0.000701	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6R—rheumatoid arthritis	0.000461	0.000699	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL10—rheumatoid arthritis	0.000461	0.000698	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP3—rheumatoid arthritis	0.00042	0.000637	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TYK2—rheumatoid arthritis	0.00042	0.000637	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTK2—rheumatoid arthritis	0.000405	0.000613	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	0.000403	0.00061	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL5—rheumatoid arthritis	0.000397	0.000601	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CSF2—rheumatoid arthritis	0.000391	0.000592	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2—rheumatoid arthritis	0.000385	0.000583	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SPP1—rheumatoid arthritis	0.000367	0.000557	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	0.000366	0.000554	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR5—rheumatoid arthritis	0.000357	0.000542	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2RA—rheumatoid arthritis	0.000352	0.000534	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2—rheumatoid arthritis	0.000349	0.00053	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C3—rheumatoid arthritis	0.000349	0.000529	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LEP—rheumatoid arthritis	0.000325	0.000493	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FN1—rheumatoid arthritis	0.000307	0.000465	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6ST—rheumatoid arthritis	0.000305	0.000463	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CD80—rheumatoid arthritis	0.000294	0.000445	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—POMC—rheumatoid arthritis	0.000279	0.000423	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL2—rheumatoid arthritis	0.000273	0.000414	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6R—rheumatoid arthritis	0.000272	0.000413	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TYK2—rheumatoid arthritis	0.000248	0.000376	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOS3—rheumatoid arthritis	0.000244	0.000369	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL8—rheumatoid arthritis	0.000216	0.000327	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2—rheumatoid arthritis	0.000206	0.000313	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—rheumatoid arthritis	0.000205	0.000311	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—rheumatoid arthritis	0.000195	0.000296	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NFKB1—rheumatoid arthritis	0.000193	0.000293	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MAPK8—rheumatoid arthritis	0.00019	0.000288	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—rheumatoid arthritis	0.000175	0.000266	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—rheumatoid arthritis	0.000161	0.000244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TP53—rheumatoid arthritis	0.000133	0.000201	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—rheumatoid arthritis	0.000121	0.000184	CbGpPWpGaD
